Currently out of the existing stock ratings of Eva Fortea Verdejo, 2 are a SELL (3.39%), 14 are a HOLD (23.73%), 43 are a BUY (72.88%).
Analyst Eva Fortea Verdejo, currently employed at WELLS FARGO, has had 59.64% of price targets met with an average potential upside of 39.42%, reached in 129 days on average.
Eva Fortea Verdejo has documented 118 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BCAX, at 12-Aug-2026.
Analyst best performing recommendations are on RCUS (ARCUS BIOSCIENCES).
The best stock recommendation documented was for ZYME (ZYMEWORKS) on 11/19/2025. The price target of $25 was fulfilled within 6 days with a profit of $2.4 (10.62%), with a performance score of 17.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Dec-2024
$36
$25.98 (259.28%)
$42
5 days ago
(11-Nov-2026)
Buy Since 08-Oct-2024
$43
$32.98 (329.14%)
$46
6 days ago
(10-Nov-2026)
Buy Since 08-Jan-2026
$37
$26.98 (269.26%)
$39
6 days ago
(10-Nov-2026)
Buy Since 08-Oct-2024
$30
$19.98 (199.40%)
$39
6 days ago
(10-Nov-2026)
Hold Since 31-Mar-2026
$8
$-2.02 (-20.16%)
$20
17 days ago
(30-Oct-2026)
4/4 (100%)
$-1.13 (-12.38%)
100
Which stock is Eva Fortea Verdejo most bullish on?
Which stock is Eva Fortea Verdejo most reserved on?
What Year was the first public recommendation made by Eva Fortea Verdejo?